436.80USD+0.52%Mkt Cap: 110.61B USDP/E: 25.85Last update: 2026-05-26
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on spec…
Industry Peers
Biotechnology106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
31.10BUSDP/E 28.4
Indicators:|
Key Statistics
Company
Market Cap110.61B USD
Enterprise Value104.77B USD
Revenue (TTM)12.22B USD
Gross Profit10.35B USD
Net Income (TTM)3.95B USD
Revenue/Share47.91 USD
Last Price436.80 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6.4K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)25.85
P/E (Forward)20.16
PEG1.62
EV/EBITDA21.03
EV/Revenue8.58
P/S9.01
P/B5.69
EPS (TTM)16.86
EPS (Forward)21.50
52W Range
362.5051% of range507.92
52W High507.92 USD
52W Low362.50 USD
Profitability
Gross Margin86.24%
Oper. Margin38.13%
EBITDA Margin40.77%
Profit Margin32.94%
ROE21.18%
ROA15.42%
Growth
Revenue Growth7.80%
Earnings Growth61.40%
Cash Flow & Leverage
Operating CF3.63B USD
CapEx (TTM)437.60M USD
FCF Margin22.78%
FCF Yield2.52%
Net Debt-5.26B USD
Net Debt/EBITDA-1.06
Balance Sheet
Debt/Equity0.11
Current Ratio3.02
Quick Ratio2.38
Book Value/Sh76.18 USD
Cash/Share28.55 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateAug 24, 2000
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)548.10 USD
Target Range330.00 USD – 641.00 USD
# Analysts29
Ownership
Shares Out.253.81M
Float253.02M
Insiders0.21%
Institutions98.01%
Short Interest
Short Ratio3.7d
Short % Float1.86%
Short % Out.1.64%
Shares Short4.17M
Short (prev mo.)4.02M
Technical
SMA 50441.16 (-1.0%)
SMA 200434.50 (+0.5%)
Beta0.30
S&P 52W Chg28.31%
Avg Vol (30d)1.18M
Avg Vol (10d)1.30M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—